The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study-Reference-Cited by-同舟云学术

The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study

Published:2006-01-13 Issue:3 Volume:19 Page:417-428
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ordóñez Nelson G

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800544.pdf

Reference82 articles.

1. Attanoos RL, Gibbs AR . Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 2003;43:444–452.

2. Kobashi Y, Okimoto N, Sakamoto K . Squamous cell carcinoma of the lung producing granulocyte colony-stimulating factor and resembling a malignant pleural mesothelioma. Intern Med 2004;43:111–116.

3. Pritchard SA, Howat AJ, Edwards JM . Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma (letter). Histopathology 2003;43:197–199.

4. Attanoos RL, Thomas DH, Gibbs AR . Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals. Histopathology 2003;43:387–392.

5. French CA, Sugarbaker DJ, Corson JM . Synchronous pleural mesothelioma and primary lung carcinoma. Mod Pathol 1999;12:183A.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesothelioma: molecular pathology and biomarkers;Die Pathologie;2024-08-07

2. Malignant and borderline mesothelial tumors of the pleura;Practical Pulmonary Pathology;2024

3. An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers;Archives of Pathology & Laboratory Medicine;2023-08-25

4. Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall;Cancer Cytopathology;2023-04-17

5. Mesothelioma: Overview of Technical, Immunochemical and Pathomorphological Diagnosing Aspects;Mesothelioma - Diagnostics, Treatment and Basic Research;2022-12-21